A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Clinical trial NCT05859074 · RECRUITING

Trial details

NCT number: NCT05859074
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma SCC - Squamous Cell Carcinoma Basal Cell Carcinoma BCC BCC - Basal Cell Carcinoma Melanoma Merkel Cell Carcinoma Sebaceous Carcinoma Extramammary Paget Disease Kaposi Sarcoma Head and Neck Squamous Cell Carcinoma HNSCC

Start date: 2023-05-04
Primary completion: 2028-05-04
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.